Quadcap Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Quadcap Wealth Management's BMY Position: Q1 2026 in Review
Quadcap Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 58% in Q1 2026, buying an estimated $398K and bringing the position to 18,578 shares worth $1.13M. The position accounts for 0.13% of the portfolio, ranked #149.
Quadcap Wealth Management first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Quadcap Wealth Management held 18,578 shares of Bristol-Myers Squibb worth $1.13M as of Q1 2026.
- Quadcap Wealth Management bought 6,824 Bristol-Myers Squibb shares in Q1 2026, an estimated $398K.
- Bristol-Myers Squibb made up 0.13% of Quadcap Wealth Management's portfolio in Q1 2026, its #149 holding.
- Quadcap Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Quadcap Wealth Management's 13F filing for Q1 2026, filed 15 May 2026.